SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ANTIGENICS INC
(NQSC:AGEN Last Sale: 2.72 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (AGEN : $2.72)
$198 million Market Cap at September 12, 2013
Employs 275.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
630 Fifth Avenue Research Report Earnings Snapshot - Last 10/31/18
Suite 2100 Fact Sheet
New York, NY 10111 Financial Statements
Phone: (212) 994-8200 Peer Comparison
Annual Reports

Garo H. Armen, Chmn./Pres./CEO, Peter Thornton, CFO
Biotech firm developing heat shock proteins to treat cancers and other autoimmune diseases. IPO at $18 February 3, 2000. Raised $63 million, selling 3.5 million shares, 14% of the outstanding. Lead Manager: Piper Jaffray. Announced personal cancer vaccine showed a potential survival benefit for some skin cancer patients October 10, 2005.
Historical Charts    Technical Analysis
No Historical Data available for AGEN

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common AGEN $2.72 $ 0 $2.65 $2.8 244,680 $2.45 $5.4 72,811
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $198,046

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex